Bharat Biotech likely to start manufacturing Covaxin at Pune plant soon

Animal vaccine maker Hester Biosciences, on the other hand, is setting up a greenfield BSL-3 facility in Gujarat to make Covaxin

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Sohini Das Mumbai
Covaxin might soon be produced in the neighbourhood of Covishield after Hyderabad-based vaccine maker Bharat Biotech started engineering batches of Covaxin at Biovet’s Manjari plant near Pune. Meanwhile, Covaxin production will touch 55 mn doses a month from October.

Biovet is an associate firm of Bharat Biotech. “At present engineering batches are on at the Manjari plant. Soon, commercial production will start,” said a source close to the developments.

Engineering batches are run to test the functionality of the installed equipment. The Manjari plant spread over 12 hectares was acquired by Biovet. It is a ready to use vaccine plant that belonged

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 22 2021 | 11:33 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com